Journal - Research Article

Moebs, I., Abeln, E., Siefert, A., & Barak, Y. (2020). Potentially inappropriate medications in a psychogeriatric inpatient ward: An audit based on Beers Criteria. Neurology & Therapy. Advance online publication. doi: 10.1007/s40120-020-00188-2

Barak, Y., Leitch, S., & Glue, P. (2020). The Great Escape: Centenarians' exceptional health. Aging Clinical & Experimental Research. Advance online publication. doi: 10.1007/s40520-020-01552-w

Barak, Y., Cheung, G., Fortune, S., & Glue, P. (2020). No country for older men: Ageing male suicide in New Zealand. Australasian Psychiatry. Advance online publication. doi: 10.1177/1039856220905304

Gale, C., & Barak, Y. (2020). Euthanasia, medically assisted dying or assisted suicide: Time for psychiatrists to say no. Australasian Psychiatry, 28(2), 160-163. doi: 10.1177/1039856219878645

Barak, Y., Gray, A. R., Rapsey, C., & Scott, K. (2020). The Dunedin Dementia Risk Awareness Project: Pilot study in older adults. International Psychogeriatrics, 32(2), 241-254. doi: 10.1017/s1041610219000772

Choo, T., Barak, Y., & East, A. (2019). The effects of intuitive movement reembodiment on the quality of life of older adults with dementia: A pilot study. American Journal of Alzheimer's Disease & Other Dementias, 35, 1-7. doi: 10.1177/1533317519860331

Barak, Y., Leitch, S., & Greco, P. (2019). Identifying hoarding disorder in the elderly using the interRAI. Archives of Gerontology & Geriatrics, 80, 95-97. doi: 10.1016/j.archger.2018.10.014

Cheung, G., Wright-St Clair, V., Chacko, E., & Barak, Y. (2019). Financial difficulty and biopsychosocial predictors of loneliness: A cross-sectional study of community dwelling older adults. Archives of Gerontology & Geriatrics, 85, 103935. doi: 10.1016/j.archger.2019.103935

Ohana, I., Golander, H., & Barak, Y. (2018). Aging of Holocaust survivors: Discrepancies between subjective and general health in the greater Tel Aviv area. Israel Medical Association Journal, 20, 207-210.

Leitch, S., Glue, P., Gray, A. R., Greco, P., & Barak, Y. (2018). Comparison of psychosocial variables associated with loneliness in centenarian vs elderly populations in New Zealand. JAMA Network Open, 1(6), e183880. doi: 10.1001/jamanetworkopen.2018.3880

Barak, Y., Rapsey, C., Fridman, D., & Scott, K. (2018). The Dunedin Dementia Risk Awareness Project: A convenience sample of general practitioners. New Zealand Medical Journal, 131(1474), 27-34. Retrieved from https://www.nzma.org.nz/journal

Tzvieli, A., Zaig, T., Ayal, I., Thieberger, G., Rothschild, S., & Barak, Y. (2017). The impact of self-directed Voice of Love messages on anger: A pilot study. Advances in Mind-Body Medicine, 31(2), 12-15.

Barak, Y., & Fridman, D. (2017). Impact of Mediterranean diet on cancer: Focused literature review. Cancer Geonomics & Proteomics, 14(6), 403-408. doi: 10.21873/cgp.20050

Briskman, I., Shelef, A., Berger, U., Baruch, Y., Bar, G., Asherov, J., … Barak, Y. (2017). Deliberate self-harm in older adults: A general hospital emergency department survey. Israel Medical Association Journal, 19(3), 160-163.

Rothschild, S., Kaplan, G., Golan, T., & Barak, Y. (2017). Mindfulness meditation in the Israel Defense Forces: Effect on cognition and satisfaction with life: A randomized controlled trial. European Journal of Integrative Medicine, 10, 71-74. doi: 10.1016/j.eujim.2017.01.010

Barak, Y., Finkelstein, I., & Pridan, S. (2016). The geriatric mania asenapine study (GeMS). Archives of Gerontology & Geriatrics, 64, 111-114. doi: 10.1016/j.archger.2016.01.012

Shelef, A., Zdaka, C., & Barak, Y. (2015). Happiness amongst Israel Defense Force (IDF) Mental Health Officers (MHO’s). Disaster & Military Medicine, 1(7). doi: 10.1186/2054-314X-1-7

Kertesz, D. P., Swartz, M. V., Tadger, S., Plopski, I., & Barak, Y. (2015). Tetrabenazine for tardive tremor in elderly adults: A prospective follow-up study. Clinical Neuropharmacology, 38(1), 23-25. doi: 10.1097/wnf.0000000000000061

Shelef, A., Mazeh, D., Berger, U., Baruch, Y., & Barak, Y. (2015). Acute electroconvulsive therapy followed by maintenance electroconvulsive therapy decreases hospital re-admission rates of older patients with severe mental illness. Journal of ECT, 31(2), 125-128. doi: 10.1097/yct.0000000000000197

Valencia, M., Fresán, A., Barak, Y., Juárez, F., Escamilla, R., & Saracco, R. (2015). Predicting functional remission in patients with schizophrenia: A cross-sectional study of symptomatic remission, psychosocial remission, functioning, and clinical outcome. Neuropsychiatric Disease & Treatment, 11, 2339-2348. doi: 10.2147/ndt.s87335

Pridan, S., Swartz, M., Baruch, Y., Tadger, S., Plopski, I., & Barak, Y. (2015). Effectiveness and safety of clozapine in elderly patients with chronic resistant schizophrenia. International Psychogeriatrics, 27(1), 131-134. doi: 10.1017/s1041610214001756

Achiron, A., Givon, U., Magalashvili, D., Dolev, M., Zaltzman, S. L., Kalron, A., … Barak, Y. (2015). Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study. Multiple Sclerosis Journal, 21(6), 767-775. doi: 10.1177/1352458514554053

Klang, S. H., Ben-Amnon, Y., Cohen, Y., & Barak, Y. (2015). Community pharmacists' support improves antidepressant adherence in the community. International Clinical Psychopharmacology, 30(6), 316-319. doi: 10.1097/yic.0000000000000090

Ohana, I., Golander, H., & Barak, Y. (2014). Balancing psychache and resilience in aging Holocaust survivors. International Psychogeriatrics, 26(6), 929-934. doi: 10.1017/s104161021400012x

Raviv, G., Laufer, M., Baruch, Y., & Barak, Y. (2014). Risk of prostate cancer in patients with schizophrenia. Comprehensive Psychiatry, 55(7), 1639-1642. doi: 10.1016/j.comppsych.2014.05.007

Nehama, Y., Rabinowitz, I., Baruch, Y., Mandel, A., Lurie, I., & Barak, Y. (2014). Debunking the placebo effect in depression: The effect of patient and investigator expectation on escitalopram efficacy. International Clinical Psychopharmacology, 29(2), 106-110. doi: 10.1097/yic.0000000000000013

Or, A., Baruch, Y., Tadger, S., & Barak, Y. (2014). Real-life decision making of Serious Mental Illness patients: Opt-in and opt-out research participation. Israel Journal of Psychiatry & Related Sciences, 51(3), 199-203.

Shelef, A., Hiss, J., Cherkashin, G., Berger, U., Aizenberg, D., Baruch, Y., & Barak, Y. (2014). Psychosocial and medical aspects of older suicide completers in Israel: A 10-year survey. International Journal of Geriatric Psychiatry, 29(8), 846-851. doi: 10.1002/gps.4070

Bergman, Y., & Barak, Y. (2013). Escitalopram for antipsychotic nonresponsive visual hallucinosis: Eight patients suffering from Charles Bonnet syndrome. International Psychogeriatrics, 25(9), 1433-1436. doi: 10.1017/s1041610213000719

Achiron, A., Chapman, J., Magalashvili, D., Dolev, M., Lavie, M., Bercovich, E., … Barak, Y. (2013). Modeling of cognitive impairment by disease duration in multiple sclerosis: A cross-sectional study. PLoS ONE, 8(8), e71058. doi: 10.1371/journal.pone.0071058

Barak, Y., & Aizenberg, D. (2012). Clinical and psychosocial remission in schizophrenia: correlations with antipsychotic treatment. BMC Psychiatry, 12, 108. doi: 10.1186/1471-244x-12-108

Barak, Y., Plopski, I., Tadger, S., & Paleacu, D. (2011). Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: A randomized double-blind pilot study. International Psychogeriatrics, 23(9), 1515-1519. doi: 10.1017/s1041610211000743

Barak, Y., Swartz, M., & Baruch, Y. (2011). Venlafaxine or a second SSRI: Switching after treatment failure with an SSRI among depressed inpatients: A retrospective analysis. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 35(7), 1744-1747. doi: 10.1016/j.pnpbp.2011.06.007

Barak, Y., & Aizenberg, D. (2011). Switching to aripiprazole as a strategy for weight reduction: A meta-analysis in patients suffering from schizophrenia. Journal of Obesity, 2011, 898013. doi: 10.1155/2011/898013

Barak, Y., Levy, D., Szor, H., & Aizenberg, D. (2011). First-onset functional brief psychoses in the elderly. Canadian Geriatrics Journal, 14(2), 30-33.

Tadger, S., Paleacu, D., & Barak, Y. (2011). Quetiapine augmentation of antidepressant treatment in elderly patients suffering from depressive symptoms: A retrospective chart review. Archives of Gerontology & Geriatrics, 53(1), 104-105. doi: 10.1016/j.archger.2010.06.012

Levy, T. B., Barak, Y., Sigler, M., & Aizenberg, D. (2011). Suicide attempts and burden of physical illness among depressed elderly inpatients. Archives of Gerontology & Geriatrics, 52(1), 115-117. doi: 10.1016/j.archger.2010.02.012

Ohanna, I., Golander, H., & Barak, Y. (2011). Does late onset depression predispose to dementia? A retrospective, case-controlled study. Comprehensive Psychiatry, 52(6), 659-661. doi: 10.1016/j.comppsych.2010.10.016

Barak, Y., & Aizenberg, D. (2010). Is dementia preventable? Focus on Alzheimer's disease. Expert Review of Neurotherapeutics, 10(11), 1689-1698. doi: 10.1586/ern.10.159

Briskman, I., Dubinski, R., & Barak, Y. (2010). Treating delirium in a general hospital: A descriptive study of prescribing patterns and outcomes. International Psychogeriatrics, 22(2), 328-331. doi: 10.1017/s1041610209990986

Barak, Y., Bleich, A., & Aizenberg, D. (2010). Psychosocial remission in schizophrenia: Developing a clinician-rated scale. Comprehensive Psychiatry, 51(1), 94-98. doi: 10.1016/j.comppsych.2008.11.013

Mazeh, D., Bodner, E., Weizman, R., Delayahu, Y., Cholostoy, A., Martin, T., & Barak, Y. (2009). Co-morbid social phobia in schizophrenia. International Journal of Social Psychiatry, 55(3), 198-202. doi: 10.1177/0020764008093447

Barak, Y., & Achiron, A. (2009). Happiness and neurological diseases. Expert Review of Neurotherapeutics, 9(4), 445-459. doi: 10.1586/ern.09.1

Barak, Y., Baruch, Y., Achiron, A., & Aizenberg, D. (2008). Suicide attempts of schizophrenia patients: A case-controlled study in tertiary care. Journal of Psychiatric Research, 42(10), 822-826. doi: 10.1016/j.jpsychires.2007.09.002

Wohl, Y., Aviv, A., Friedman, T., & Barak, Y. (2008). Cutaneous photodamage in schizophrenia patients. Photodermatology, Photoimmunology, & Photomedicine, 24(6), 291-295. doi: 10.1111/j.1600-0781.2008.00378.x

Barak, Y. (2008). Breast cancer in women suffering from serious mental illness. Schizophrenia Research, 102(1-3), 249-253. doi: 10.1016/j.schres.2008.03.017

Rabinowitz, I., Baruch, Y., & Barak, Y. (2008). High-dose escitalopram for the treatment of obsessive-compulsive disorder. International Clinical Psychopharmacology, 23(1), 49-53. doi: 10.1097/YIC.0b013e3282f0f0c5

Paleacu, D., Barak, Y., Mirecky, I., & Mazeh, D. (2008). Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: A 6-week, double-blind, placebo-controlled study. International Journal of Geriatric Psychiatry, 23(4), 393-400. doi: 10.1002/gps.1892

Abramowitz, E. G., Barak, Y., Ben-Avi, I., & Knobler, H. Y. (2008). Hypnotherapy in the treatment of chronic combat-related PTSD patients suffering from insomnia: A randomized, Zolpidem-controlled clinical trial. International Journal of Clinical & Experimental Hypnosis, 56(3), 270-280. doi: 10.1080/00207140802039672

Werner, P., Aviv, A., & Barak, Y. (2008). Self-stigma, self-esteem and age in persons with schizophrenia. International Psychogeriatrics, 20(1), 174-187. doi: 10.1017/s1041610207005340

Barak, Y. (2008). Co-prescription of antidepressants with other psychotropics: Distinct profile of escitalopram. International Journal of Psychiatry in Clinical Practice, 12(1), 31-35. doi: 10.1080/13651500701419701

Simeoni, M. C., Auquier, P., Fernandez, O., Flachenecker, P., Stecchi, S., Constantinescu, C. S., … Barak, Y., … Pelletier, J., on behalf of the MusiQoL study group (2008). Validation of the Multiple Sclerosis International Quality of Life questionnaire. Multiple Sclerosis Journal, 14(2), 219-230. doi: 10.1177/1352458507080733

Tadger, S., Baruch, Y., & Barak, Y. (2008). Symptomatic remission in elderly schizophrenia patients treated with long-acting risperidone. International Psychogeriatrics, 20(6), 1245-1250. doi: 10.1017/s1041610208007606

Harel, Y., Barak, Y., & Achiron, A. (2007). Dysregulation of affect in multiple sclerosis: New phenomenological approach. Psychiatry & Clinical Neurosciences, 61(1), 94-98. doi: 10.1111/j.1440-1819.2007.01616.x

Barak, Y., Baruch, Y., Mazeh, D., Paleacu, D., & Aizenberg, D. (2007). Cardiac and cerebrovascular morbidity and mortality associated with antipsychotic medications in elderly psychiatric inpatients. American Journal of Geriatric Psychiatry, 15(4), 354-356. doi: 10.1097/JGP.0b013e318030253a

Barak, Y. (2007). The aging of Holocaust survivors: Myth and reality concerning suicide. Israel Medical Association Journal, 9(3), 196-198.

Mazeh, D., Shahal, B., Aviv, A., Zemishlani, H., & Barak, Y. (2007). A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression. International Clinical Psychopharmacology, 22(6), 371-375. doi: 10.1097/YIC.0b013e32817396ae

Barak, Y., Olmer, A., & Aizenberg, D. (2006). Antidepressants reduce the risk of suicide among elderly depressed patients. Neuropsychopharmacology, 31(1), 178-181. doi: 10.1038/sj.npp.1300863

Stein, D., Weizman, A., Ring, A., & Barak, Y. (2006). Obstetric complications in individuals diagnosed with autism and in healthy controls. Comprehensive Psychiatry, 47(1), 69-75. doi: 10.1016/j.comppsych.2005.01.001

Friedman, T., Wohl, Y., Knobler, H. Y., Lubin, G., Brenner, S., Levi, Y., & Barak, Y. (2006). Increased use of mental health services related to Isotretinoin treatment: A 5-year analysis. European Neuropsychopharmacology, 16(6), 413-416. doi: 10.1016/j.euroneuro.2005.11.006

Mazeh, D., Zemishlani, H., Barak, Y., Mirecki, I., & Paleacu, D. (2006). Donepezil for negative signs in elderly patients with schizophrenia: An add-on, double-blind, crossover, placebo-controlled study. International Psychogeriatrics, 18(3), 429-436. doi: 10.1017/s1041610205003017

Barak, Y., & Aizenberg, D. (2006). Association between antidepressant prescribing and suicide in Israel. International Clinical Psychopharmacology, 21(5), 281-284.

Barak, Y. (2006). The immune system and happiness. Autoimmunity Reviews, 5(8), 523-527. doi: 10.1016/j.autrev.2006.02.010

Barak, Y., Mazeh, D., Plopski, I., & Baruch, Y. (2006). Intramuscular ziprasidone treatment of acute psychotic agitation in elderly patients with schizophrenia. American Journal of Geriatric Psychiatry, 14(7), 629-633. doi: 10.1097/01.jgp.0000216325.42721.99

Aizenberg, D., Olmer, A., & Barak, Y. (2006). Suicide attempts amongst elderly bipolar patients. Journal of Affective Disorders, 91(1), 91-94. doi: 10.1016/j.jad.2005.12.013

Rotstein, Z., Hazan, R., Barak, Y., & Achiron, A. (2006). Perspectives in multiple sclerosis health care: Special focus on the costs of multiple sclerosis. Autoimmunity Reviews, 5(8), 511-516. doi: 10.1016/j.autrev.2006.02.001

Barak, Y., Aizenberg, D., Szor, H., Swartz, M., Maor, R., & Knobler, H. Y. (2005). Increased risk of attempted suicide among aging Holocaust survivors. American Journal of Geriatric Psychiatry, 13(8), 701-4. doi: 10.1176/appi.ajgp.13.8.701

Barak, Y., Achiron, A., Mandell, M., Mirecki, I., & Aizenberg, D. (2005). Reduced cancer incidence among patients with schizophrenia. Cancer, 104(12), 2817-2821. doi: 10.1002/cncr.21574

Mazeh, D., Cholostoy, A., Zemishlani, C., & Barak, Y. (2005). Elderly psychiatric patients at risk of folic acid deficiency: A case controlled study. Archives of Gerontology & Geriatrics, 41(3), 297-302. doi: 10.1016/j.archger.2005.04.006

Achiron, A., Polliack, M., Rao, S. M., Barak, Y., Lavie, M., Appelboim, N., & Harel, Y. (2005). Cognitive patterns and progression in multiple sclerosis: Construction and validation of percentile curves. Journal of Neurology, Neurosurgery & Psychiatry, 76(5), 744-749. doi: 10.1136/jnnp.2004.045518

Achiron, A., Barak, Y., Gail, M., Mandell, M., Pee, D., Ayyagari, R., & Rotstein, Z. (2005). Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments. Breast Cancer Research & Treatment, 89(3), 265-270. doi: 10.1007/s10549-004-2229-4

Mazeh, D., Zemishlani, C., Aizenberg, D., & Barak, Y. (2005). Patients with very-late-onset schizophrenia-like psychosis: A follow-up study. American Journal of Geriatric Psychiatry, 13(5), 417-419. doi: 10.1176/appi.ajgp.13.5.417

Stein, D., Zemishlani, C., Shahal, B., & Barak, Y. (2005). Disordered eating in elderly female patients diagnosed with chronic schizophrenia. Israel Journal of Psychiatry & Related Sciences, 42(3), 191-197.

Barak, Y., Swartz, M., & Plopsky, I. (2005). Assessing cardiovascular risks of olanzapine treatment: A 6-month study versus haloperidol in schizophrenia patients. International Clinical Psychopharmacology, 20(6), 315-317.

Barak, Y., Wohl, Y., Greenberg, Y., Dayan, Y. B., Friedman, T., Shoval, G., & Knobler, H. Y. (2005). Affective psychosis following Accutane (isotretinoin) treatment. International Clinical Psychopharmacology, 20(1), 39-41.

Barak, Y., Davidson, M., Luxenberg, J. S., & Aizenberg, D. (2004). Psychiatric services in nursing homes in Israel: Should the American legislation be adopted? Israel Journal of Psychiatry & Related Sciences, 41(3), 213-217.

Achiron, A., Kishner, I., Sarova-Pinhas, I., Raz, H., Faibel, M., Stern, Y., … Barak, Y. (2004). Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: A randomized, double-blind, placebo-controlled trial. Archives of Neurology, 61(10), 1515-1520. doi: 10.1001/archneur.61.10.1515

Drimer, T., Shahal, B., & Barak, Y. (2004). Effects of discontinuation of long-term anticholinergic treatment in elderly schizophrenia patients. International Clinical Psychopharmacology, 19(1), 27-9. doi: 10.1097/01.yic.0000102048.1367.4c

Barak, Y., Shamir, E., Mirecki, I., Weizman, R., & Aizenberg, D. (2004). Switching elderly chronic psychotic patients to olanzapine. International Journal of Neuropsychopharmacology, 7(2), 165-169. doi: 10.1017/s1461145703004048

Barak, Y., Mirecki, I., Knobler, H. Y., & Natan, Z. (2004). Suicidality and second generation antipsychotics in schizophrenia patients: A case-controlled retrospective study during a 5-year period. Psychopharmacology, 175(2), 215-219. doi: 10.1007/s00213-004-1801-2

Barak, Y., Knobler, C. Y., & Aizenberg, D. (2004). Suicide attempts amongst elderly schizophrenia patients: A 10-year case-control study. Schizophrenia Research, 71(1), 77-81. doi: 10.1016/j.schres.2003.12.001

Barak, Y., Cohen, A., & Aizenberg, D. (2004). Suicide among the homeless: A 9-year case-series analysis. Crisis, 25(2), 51-53. doi: 10.1027/0227-5910.25.2.51

Achiron, A., Edelstein, S., Ziev-Ner, Y., Givon, U., Rotstein, Z., & Barak, Y. (2004). Bone strength in multiple sclerosis: Cortical midtibial speed-of-sound assessment. Multiple Sclerosis, 10(5), 488-493. doi: 10.1191/1352458504ms1076oa

Remnik, Y., Melamed, Y., Swartz, M., Elizur, A., & Barak, Y. (2004). Patients' satisfaction with psychiatric inpatient care. Israel Journal of Psychiatry & Related Sciences, 41(3), 208-212.

Barak, Y., & Aizenberg, D. (2003). Effects of olanzapine on lipid abnormalities in elderly psychotic patients. Drugs & Aging, 20(12), 893-896.

Barak, Y., Aizenberg, D., & Achiron, A. (2003). Concordance for cognitive impairment: A study of 50 community-dwelling elderly female-female twin pairs. Comprehensive Psychiatry, 44(2), 117-120. doi: 10.1053/comp.2003.50019

Barak, Y., Swartz, M., Levy, D., & Weizman, R. (2003). Age-related differences in the side effect profile of citalopram. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 27(3), 545-548. doi: 10.1016/s0278-5846(03)00041-1

Achiron, A., Barak, Y., & Rotstein, Z. (2003). Longitudinal disability curves for predicting the course of relapsing-remitting multiple sclerosis. Multiple Sclerosis, 9(5), 486-491. doi: 10.1191/1352458503ms945oa

Achiron, A., & Barak, Y. (2003). Cognitive impairment in probable multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry, 74(4), 443-446. doi: 10.1136/jnnp.74.4.443

Aizenberg, D., Weizman, A., & Barak, Y. (2003). Sildenafil for selective serotonin reuptake inhibitor-induced erectile dysfunction in elderly male depressed patients. Journal of Sex & Marital Therapy, 29(4), 297-303. doi: 10.1080/00926230390195533

Barak, Y., & Cohen, A. (2003). Characterizing the elderly homeless: A 10-year study in Israel. Archives of Gerontology & Geriatrics, 37(2), 147-155.

Mazeh, D., Melamed, Y., & Barak, Y. (2003). Emergency psychiatry: Treatment of referred psychiatric patients by general hospital emergency department physicians. Psychiatric Services, 54(9), 1221-1223. doi: 10.1176/appi.ps.54.9.1221

Hadjez, J., Stein, D., Gabbay, U., Bruckner, J., Meged, S., Barak, Y., … Rotenberg, V. S. (2003). Dream content of schizophrenic, nonschizophrenic mentally ill, and community control adolescents. Adolescence, 38(150), 331-342.

Jeste, D. V., Barak, Y., Madhusoodanan, S., Grossman, F., & Gharabawi, G. (2003). International multisite double-blind trial of the atypical antipsychotics risperidone and olanzapine in 175 elderly patients with chronic schizophrenia. American Journal of Geriatric Psychiatry, 11(6), 638-647.

Barak, Y., & Achiron, A. (2002). Effect of interferon-beta-1b on cognitive functions in multiple sclerosis. European Neurology, 47(1), 11-14. doi: 10.1159/000047940

Aizenberg, D., Sigler, M., Weizman, A., & Barak, Y. (2002). Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: A 4-year case-control study. International Psychogeriatrics, 14(3), 307-310.

Barak, Y., Lavie, M., & Achiron, A. (2002). Screening for early cognitive impairment in multiple sclerosis patients using the clock drawing test. Journal of Clinical Neuroscience, 9(6), 629-632. doi: 10.1054/jocn.2002.1110

Milstein, A., Pollack, A., Kleinman, G., & Barak, Y. (2002). Confusion/delirium following cataract surgery: An incidence study of 1-year duration. International Psychogeriatrics, 14(3), 301-306. doi: 10.1017/S1041610202008499

Barak, Y., Shamir, E., & Weizman, R. (2002). Would a switch from typical antipsychotics to risperidone be beneficial for elderly schizophrenic patients? A naturalistic, long-term, retrospective, comparative study. Journal of Clinical Psychopharmacology, 22(2), 115-120.

Paleacu, D., Mazeh, D., Mirecki, I., Even, M., & Barak, Y. (2002). Donepezil for the treatment of behavioral symptoms in patients with Alzheimer's disease. Clinical Neuropharmacology, 25(6), 313-317.